The Enterprise Value as of December 2025 (TTM) for ProMIS Neurosciences, Inc. (PMN) is -5422421.00

According to ProMIS Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -5422421.00. This represents a change of -145.78% compared to the average of 11.84M of the last 4 quarters.

ProMIS Neurosciences, Inc. (PMN) Historical Enterprise Value (quarterly & annually)

How has PMN Enterprise Value performed in the past?

The mean historical Enterprise Value of ProMIS Neurosciences, Inc. over the last ten years is 26.95M. The current -5422421.00 Enterprise Value has changed -2111.83% with respect to the historical average. Over the past ten years (40 quarters), PMN's Enterprise Value was at its highest in in the March 2018 quarter at 102.27M. The Enterprise Value was at its lowest in in the September 2025 quarter at -580434.76.

ProMIS Neurosciences, Inc. (PMN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ProMIS Neurosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ProMIS Neurosciences, Inc. (PMN) Average Enterprise Value

How has PMN Enterprise Value performed in the past?

The current Enterprise Value of ProMIS Neurosciences, Inc. (PMN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ProMIS Neurosciences, Inc. (PMN) Enterprise Value vs. Peers

How is PMN’s Enterprise Value compared to its peers?

ProMIS Neurosciences, Inc.’s Enterprise Value is less than MapLight Therapeutics, Inc. (0), less than Ernexa Therapeutics Inc. (7.79M), less than OSR Holdings, Inc. (15.64M), less than Lipocine Inc. (10.58M), less than Adaptimmune Therapeutics plc (97.78M), less than Edesa Biotech, Inc. (-471391.00), less than Adlai Nortye Ltd. (3.81M), less than GeoVax Labs, Inc. (4.72M), less than Tharimmune, Inc. (84.57M), less than BioRestorative Therapies, Inc. (7.90M),

Build a custom stock screener for ProMIS Neurosciences, Inc. (PMN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProMIS Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ProMIS Neurosciences, Inc. (PMN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ProMIS Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.